Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

Lenalidomide Based Immunotherapy in the Treatment of DLBCL

NCT03715296 ·Status: UNKNOWN

Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases

NCT00538551 ·Status: UNKNOWN

A Registry for People With T-cell Lymphoma

NCT05978141 ·Status: RECRUITING

Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia

NCT02618109 ·Status: TERMINATED ·Phase: PHASE4

Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

NCT00049413 ·Status: COMPLETED ·Phase: PHASE2

Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

NCT00765245 ·Status: COMPLETED ·Phase: PHASE2

Institut Paoli Calmettes Chronic Lymphatic Leukemia Database

NCT02869529 ·Status: RECRUITING

Brazilian Network for Lymphoma Registry

NCT02265497 ·Status: RECRUITING

Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma

NCT00126191 ·Status: TERMINATED ·Phase: PHASE2

Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia

NCT01013961 ·Status: TERMINATED ·Phase: PHASE2

Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia

NCT00324779 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY2584702 in Solid Tumors

NCT01241461 ·Status: COMPLETED ·Phase: PHASE1

Real-World Study of DLBCL With Different Genetic Subtypes

NCT06026488 ·Status: RECRUITING

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia

NCT00133991 ·Status: COMPLETED ·Phase: PHASE2

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant

NCT01419795 ·Status: TERMINATED ·Phase: PHASE2

Rituximab Combined With Chidamide and Lenalidomide for r/r AITL

NCT04319601 ·Status: UNKNOWN ·Phase: NA

Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen

NCT01478269 ·Status: COMPLETED

Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

NCT00429065 ·Status: UNKNOWN

A Study of LY2835219 in Japanese Participants With Advanced Cancer

NCT02014129 ·Status: COMPLETED ·Phase: PHASE1

Treatment of Aggressive Localized Lymphoma

NCT00841945 ·Status: TERMINATED ·Phase: PHASE3

A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients

NCT04139252 ·Status: UNKNOWN

Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT00968331 ·Status: TERMINATED ·Phase: PHASE2

The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)

NCT01266668 ·Status: COMPLETED

Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy

NCT01625741 ·Status: TERMINATED ·Phase: PHASE2

Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)

NCT01446133 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2